Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
Kunihiro Suzuki(Kyushu University), Yoichi Nakanishi(Kyushu University Hospital)
Cited by 13
Related Papers
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
|OncoTargets and Therapy|2014|35